[HTML][HTML] Risk factors and preventions of breast cancer
YS Sun, Z Zhao, ZN Yang, F Xu, HJ Lu… - … journal of biological …, 2017 - ncbi.nlm.nih.gov
Breast cancer is the second leading cause of cancer deaths among women. The
development of breast cancer is a multi-step process involving multiple cell types, and its …
development of breast cancer is a multi-step process involving multiple cell types, and its …
Awareness and current knowledge of breast cancer
Breast cancer remains a worldwide public health dilemma and is currently the most common
tumour in the globe. Awareness of breast cancer, public attentiveness, and advancement in …
tumour in the globe. Awareness of breast cancer, public attentiveness, and advancement in …
Endometrial cancer
F Amant, P Moerman, P Neven, D Timmerman… - The Lancet, 2005 - thelancet.com
Each year, endometrial cancer develops in about 142 000 women worldwide, and an
estimated 42 000 women die from this cancer. The typical age-incidence curve for …
estimated 42 000 women die from this cancer. The typical age-incidence curve for …
Estrogen carcinogenesis in breast cancer
JD Yager, NE Davidson - New England Journal of Medicine, 2006 - Mass Medical Soc
Estrogen Carcinogenesis in Breast Cancer | New England Journal of Medicine Skip to main
content The New England Journal of Medicine homepage Advanced Search SEARCH …
content The New England Journal of Medicine homepage Advanced Search SEARCH …
Personalized early detection and prevention of breast cancer: ENVISION consensus statement
Abstract The European Collaborative on Personalized Early Detection and Prevention of
Breast Cancer (ENVISION) brings together several international research consortia working …
Breast Cancer (ENVISION) brings together several international research consortia working …
Efficacy of MRI and mammography for breast-cancer screening in women with a familial or genetic predisposition
M Kriege, CTM Brekelmans, C Boetes… - … England Journal of …, 2004 - Mass Medical Soc
Background The value of regular surveillance for breast cancer in women with a genetic or
familial predisposition to breast cancer is currently unproven. We compared the efficacy of …
familial predisposition to breast cancer is currently unproven. We compared the efficacy of …
[HTML][HTML] Cancer incidence and mortality in Europe, 2004
P Boyle, J Ferlay - Annals of oncology, 2005 - Elsevier
Background There are no recent estimates of the incidence and mortality from cancer at a
European level. Those data that are available generally refer to the mid-1990s and are of …
European level. Those data that are available generally refer to the mid-1990s and are of …
Contradicted and initially stronger effects in highly cited clinical research
JPA Ioannidis - Jama, 2005 - jamanetwork.com
ContextControversy and uncertainty ensue when the results of clinical research on the
effectiveness of interventions are subsequently contradicted. Controversies are most …
effectiveness of interventions are subsequently contradicted. Controversies are most …
Effects of tamoxifen vs raloxifene on the risk of develo** invasive breast cancer and other disease outcomes: the NSABP Study of Tamoxifen and Raloxifene (STAR) …
VG Vogel, JP Costantino, DL Wickerham, WM Cronin… - Jama, 2006 - jamanetwork.com
ContextTamoxifen is approved for the reduction of breast cancer risk, and raloxifene has
demonstrated a reduced risk of breast cancer in trials of older women with osteoporosis …
demonstrated a reduced risk of breast cancer in trials of older women with osteoporosis …
Folate and ageing
RC Coombes, LS Kilburn, CF Snowdon - cancer, 2004 - thelancet.com
The FACIT trial of folic acid supple mentation in older adults by Jane Durga and colleagues
(Jan 20, p 208) 1 adds to the growing evidence of the importance of folate to the nervous …
(Jan 20, p 208) 1 adds to the growing evidence of the importance of folate to the nervous …